Moonwalk Biosciences, founded in San Francisco, California, is a pioneering genomic medicine startup focused on developing precision epigenetic therapeutics. The company's core mission is to revolutionize the way therapies are discovered and developed by providing a comprehensive view of the epigenome in health and disease. Utilizing advanced artificial intelligence, Moonwalk's profiling and engineering technology platform aims to reprogram cells to their healthy state, offering a novel approach to medical treatments.

Notable affiliated individuals and investors include leading experts in genomics and biotechnology, although specific names are not disclosed. Key achievements include being the first company to couple an epigenetic discovery platform with precise engineering, opening up new target spaces within the epigenome for complex diseases. Moonwalk Biosciences' impact lies in its innovative approach to precision medicine, potentially transforming therapeutic development and offering new hope for treating various health conditions.